A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

A new study from the Hebrew University of Jerusalem suggests that non-intoxicating cannabis compounds CBD and CBG may help ...

CBD and CBG may help the liver recharge and clean itself—offering a promising new plant-based strategy against fatty liver disease.

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for ...

FDA grants orphan drug status to orziloben for intestinal failure-associated liver disease (90)Orziloben secures FDA orphan ...

Fatty liver is rising even among non-drinkers. A gastroenterologist explains the causes, lifestyle risks, early warning signs, and prevention tips for non-alcoholic fatty liver disease.

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

A woman with cancer that spread to her liver is getting a second chance at life after receiving an organ transplant from a living donor at Northwestern Medicine in Chicago.